Trials / Completed
CompletedNCT05008900
Timing of Post-prostatectomy PSMA Imaging
A Phase II Randomized Feasibility Study Comparing Early Salvage Radiotherapy Versus Surveillance With Delayed Repeat PSMA PET/CT Imaging in Patients Presenting With Early Biochemical Relapse of Prostate Cancer Following Radical Prostatectomy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will randomize patients presenting with early BCR with a negative baseline PSMA PET/CT, to upfront SRT or surveillance. Early BCR is defined as a PSA relapse of \>0.1 to \<0.3 ng/mL. Patients in the surveillance arm will be monitored with PSA every 3 months. A repeat PSMA PET/CT will be undertaken when the PSA reaches a target level of \>0.5 to \<1.0 ng/mL. Both early radiation treatment and surveillance with repeat PSMA PET/CT imaging are within patterns of practice locally; therefore, the investigators believe that there is clinical equipoise on this subject.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Salvage radiotherapy | Standard of care salvage radiotherapy to the prostate bed which may include the lymph nodes. |
Timeline
- Start date
- 2022-03-22
- Primary completion
- 2024-07-08
- Completion
- 2024-07-08
- First posted
- 2021-08-17
- Last updated
- 2026-03-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05008900. Inclusion in this directory is not an endorsement.